Secondary Logo

Journal Logo

Most Emailed Articles

Employment as HIV prevention: An employment support intervention for adolescent men who have sex with men and adolescent transgender women of color

Hill, Brandon J.; Motley, Darnell N.; Rosentel, Kris; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. : May 12, 2022

Five Years With Dolutegravir Plus Lamivudine as a Switch Strategy: Much More Than a Positive Finding

Ciccullo, Arturo; Borghi, Vanni; Giacomelli, Andrea; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 88(3):234-237, November 1, 2021.

The Shang Ring Device for Adult Male Circumcision: A Proof of Concept Study in Kenya

Barone, Mark A; Ndede, Frederick; Li, Philip S; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 57(1):e7-e12, May 1, 2011.

Development and Validation of a Model for Prediction of End-Stage Liver Disease in People With HIV

Kim, H. Nina; Nance, Robin M.; Lo Re, Vincent III; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 89(4):396-404, April 1, 2022.

Sexual relationship power equity is associated with consistent condom use and fewer experiences of recent violence among women living with HIV in Canada

Closson, Kalysha; Lee, Melanie; Gibbs, Andrew; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. : April 29, 2022

Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials

Rizzardini, Giuliano; Overton, Edgar T.; Orkin, Chloe; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 85(4):498-506, December 1, 2020.

Early Retention in HIV Care and Viral Load Suppression: Implications for a Test and Treat Approach to HIV Prevention

Mugavero, Michael J.; Amico, K. Rivet; Westfall, Andrew O.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 59(1):86-93, January 1, 2012.

HIV incidence in Botswana rural communities with high antiretroviral treatment coverage: Results from the Botswana Combination Prevention Project, 2013–2017

Ussery, Faith; Bachanas, Pamela; Alwano, Mary Grace; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. : May 10, 2022

Asymptomatic SARS-CoV-2 Infection is Common among ART-treated People with HIV

Overton, Edgar T.; Weir, Isabelle R.; Zanni, Markella V.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. : April 12, 2022

HIV pre-exposure prophylaxis uptake and continuation among key populations in Cameroon: Lessons learned from the CHAMP program

Ndenkeh, Jackson Nforbewing; Bowring, Anna L; Njindam, Iliassou Mfochive; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. : May 10, 2022

Implementation and Operational Research: Integration of PMTCT and Antenatal Services Improves Combination Antiretroviral Therapy Uptake for HIV-Positive Pregnant Women in Southern Zambia: A Prototype for Option B+?

Herlihy, Julie M.; Hamomba, Leoda; Bonawitz, Rachael; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 70(4):e123-e129, December 1, 2015.

Brief Report: Insomnia and Risk of Myocardial Infarction Among People With HIV

Luu, Brandon R.; Nance, Robin M.; Delaney, Joseph A. C.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 90(1):50-55, May 1, 2022.

Optima: A Model for HIV Epidemic Analysis, Program Prioritization, and Resource Optimization

Kerr, Cliff C.; Stuart, Robyn M.; Gray, Richard T.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 69(3):365-376, July 1, 2015.

Predictors of Retention in HIV Care Among Youth (15–24) in a Universal Test-and-Treat Setting in Rural Kenya

Brown, Lillian B.; Ayieko, James; Mwangwa, Florence; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 76(1):e15-e18, September 1, 2017.

Brief Report: Impact of PrEP Training for Family Planning Providers on HIV Prevention Counseling and Patient Interest in PrEP in Atlanta, Georgia

Sales, Jessica M.; Cwiak, Carrie; Haddad, Lisa B.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 81(4):414-418, August 1, 2019.

Efficacy and Safety of Rilpivirine (TMC278) Versus Efavirenz at 48 Weeks in Treatment-Naive HIV-1–Infected Patients: Pooled Results From the Phase 3 Double-Blind Randomized ECHO and THRIVE Trials

Cohen, Calvin J.; Molina, Jean-Michel; Cahn, Pedro; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 60(1):33-42, May 1, 2012.

Show: